BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 319 filers reported holding BIONTECH SE in Q4 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $216,085 | +0.7% | 1,989 | 0.0% | 0.01% | +7.7% |
| Q2 2023 | $214,673 | -13.4% | 1,989 | 0.0% | 0.01% | -18.8% |
| Q1 2023 | $247,770 | -17.1% | 1,989 | 0.0% | 0.02% | -20.0% |
| Q4 2022 | $298,788 | +11.5% | 1,989 | 0.0% | 0.02% | 0.0% |
| Q3 2022 | $268,000 | -9.8% | 1,989 | 0.0% | 0.02% | -4.8% |
| Q2 2022 | $297,000 | -11.1% | 1,989 | +1.7% | 0.02% | +10.5% |
| Q1 2022 | $334,000 | -83.7% | 1,956 | -75.3% | 0.02% | -84.6% |
| Q4 2021 | $2,043,000 | -18.4% | 7,925 | -13.6% | 0.12% | -26.3% |
| Q3 2021 | $2,505,000 | +41.7% | 9,175 | +16.2% | 0.17% | +40.3% |
| Q2 2021 | $1,768,000 | +16.5% | 7,895 | -43.2% | 0.12% | +2.6% |
| Q1 2021 | $1,517,000 | +70.6% | 13,895 | +27.5% | 0.12% | +58.9% |
| Q4 2020 | $889,000 | +54.9% | 10,895 | +32.5% | 0.07% | +40.4% |
| Q3 2020 | $574,000 | +177.3% | 8,223 | +164.6% | 0.05% | +160.0% |
| Q2 2020 | $207,000 | – | 3,108 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |